KUNAL KARIA

EDUCATION

2000-2004   Virginia Commonwealth University   Richmond, VA

• B.S. in Psychology
  
• Minor in Chemistry
  
• University Honors
  
• Summa Cum Laude
  
• College of Humanities and Sciences Award
  

2004-Current   VCU School of Medicine   Richmond, VA

• Expected graduation: May 2008

MEMBERSHIP AND HONORARY/PROFESSIONAL SOCIETIES

2004-2008

• American Medical Association (AMA)
• American Medical Student Association (AMSA)
• Recruitment & Social Chair [6/2005 – 5/2006]
• Club Med

2005

• VCU SOM Pathology Honor Society

WORK/TEACHING EXPERIENCE

2007-2008 FCM M2 Co-Leader   VCU SOM

• Full-time co-leader with Dr. Anika Alvanzo

2007-2008   Student Tutoring Program   VCU SOM

• Provided individual and group tutoring for M1 & M2 courses

June-July 2005   KOVAR Summer Institute   Petersburg, VA

• Student Fellowship at Southside Virginia Training Center
• Specifically worked with patients with mental retardation to improve their overall functioning.
• Ultimate goal for patients was ability to live in the community as independently as possible.

2003-2004   Supplemental Course Instructor   VCU

• Sociology 101 & Math 141
• Duties included attending lectures, bi-weekly supplemental teaching sessions, and exam review sessions.

2003-2004   Governor’s Scholars Program   Centre College, KY

• Counselor/Resident Advisor
• Worked two summers as a small group co-leader and R.A. for this residential summer program for outstanding high school students.

VOLUNTEER ACTIVITIES

5/2007   Co-editor of the Survival Handbook   VCU SOM

2005-2008   University Appeals Board   VCU Appeals Board

• Members of the appeals board participate in hearing appeals brought forth by students previously found guilty of violating the university's honor system.

2000-2001   Capital Medical Center   Richmond, VA

• Volunteered in various departments of the hospital.

RESEARCH EXPERIENCE

6/2007   Department of Pathology   VCU/MCVH

• Data Gatherer/Interpreter
• Title: The Immunophenotypic Expression of Nuclear Factor kB (NF-kB), Cyclin DI, and Insulin Growth Factor Binding Protein (IGFBP) in Estrogen Positive and Estrogen Negative Breast Cancer Before and After Tamoxifen and Neoadjuvant Treatment.
• Hypothesis: NF-kB activity (as measured by the amount of phosphorylated NF-kB) is elevated during progression of breast cancer, where as IGFBP-3 expression is inversely regulated.
• Specific Aims: To identify the differences in NF-kB activity and expression of BCL2, cyclin DI, and IGFBP-3 in (1) breast cancer and benign breast tissue, (2) metastatic breast carcinoma compared with non-metastatic disease, (3) recurrent breast carcinoma compared with non-recurrent disease, and (4) breast carcinoma and the relationship to the estrogen receptor, progesteron receptor, and Her2 expression.

HOBBIES/INTERESTS

• Sports (Basketball, Football, Tennis, Golf, Soccer, Hockey, and Ultimate Frisbee)
• Movies
• Leisure Reading
• Word games, puzzles, crosswords, etc
• Traveling